MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. THC is the psychoactive compound responsible for the “high” associated with marijuana use.

Law 52

Law Dispensary Clinical Trials Programs 52

Cannabis Law Report

DECEMBER 21, 2021

CBG or cannabigerol is obtained from immature cannabis plants since it is not present in fully developed plants. In most fully developed cannabis plants with considerable THC and CBD concentrations, CBG levels are relatively low. It occurs because most of the CBG has been converted to CBD and THC as the plant has matured.

Conditions 52

Conditions Research and Development Clinical Trials Oil 52

Puff Puff Post

JULY 8, 2019

. – July 8, 2019 /Canna Newswire/ – The Colorado-based Canna Research Group developed The Athlete Pain, Exercise, and Cannabis Experience (PEACE) Survey study for active adults to look beyond the stigma of cannabis use in athletes. She is the Founder & CEO of Canna Research Group. Study co-author Joanna Zeiger, MS, Ph.D.

Chronic Pain 109

Chronic Pain Research and Development Clinical Trials THC 109

Puff Puff Post

JULY 8, 2019

. – July 8, 2019 /Canna Newswire/ – The Colorado-based Canna Research Group developed The Athlete Pain, Exercise, and Cannabis Experience (PEACE) Survey study for active adults to look beyond the stigma of cannabis use in athletes. She is the Founder & CEO of Canna Research Group. Study co-author Joanna Zeiger, MS, Ph.D.

Chronic Pain 108

Chronic Pain Research and Development Clinical Trials THC 108

PrestoDoctor

SEPTEMBER 15, 2023

However, recent research suggests that cannabis may be a promising option for those seeking relief from OCD symptoms. While research is still in its early stages, some studies suggest that certain compounds found in cannabis, such as cannabidiol (CBD), may have a positive impact on reducing anxiety and intrusive thoughts associated with OCD.

Research and Development 105

Research and Development Therapy Treatment Strains 105

Cannabis Law Report

JANUARY 4, 2022

Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, has named Simon Allen as Chief Executive Officer and a member of the company’s Board of Directors, effective February 1 st , 2022. and Australia.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Cannabinoids 52

The Joint Blog

JANUARY 12, 2020

However, researchers warn that not only are not all CBD pet products made equally, but some contain no CBD at all. You’d be astounded by the analysis we’ve seen of products on the shelf with virtually no CBD in them,” said Cornell University veterinary researcher Joseph Wakshlag: He studies therapeutic uses for the compound.

Pets 36

Pets CBD Clinical Trials Research and Development 36

The Joint Blog

NOVEMBER 26, 2019

For the study, researchers at Washington State University analyzed data from 1,959 anonymous marijuana consumers who tracked their marijuana use and headache frequency over a 16-month period. Men reported larger reductions in headache than women and use of concentrates was associated with larger reductions in headache than flower.

Clinical Trials 55

Clinical Trials Research and Development Marijuana Data 55

Veriheal

AUGUST 31, 2020

Choosing only 10 winners for the $10,000 in scholarships among the strong applications we received from multiple disciplines and concentrations in higher education—from students of all backgrounds and interests—was extremely difficult. Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”.

Research and Development 117

Research and Development Education Agriculture Patients 117

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

GW Pharma carefully developed Epidiolex using cannabinoids to reduce the occurrence of seizures. Marijuana law reform advocates and many medical researchers have been fighting to change marijuana’s Schedule I classification for years. Schedule I classification typically pertains to narcotic substances with no medical value.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

The Cannigma

DECEMBER 12, 2022

Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. 19 20 21 22 23.

History 119

History Microdosing Research and Development Clinical Trials 119

The Cannigma

JUNE 15, 2021

THC is by far the most abundant and popular molecule in marijuana. The two most well known and common cannabinoids are THC and CBD, and while they won’t alter the aroma and colors of cannabis, they do interact with numerous receptor systems in the human body and have a range of effects. CBD vs THC. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JUNE 4, 2021

Dr. Titus has been involved in the development and investment of several industry-leading cannabis and industrial hemp businesses during his most recent career. Dr. Titus developed several prominent cannabis companies, including HempMeds, KannaLife Sciences Inc, and Kannaway, LLC. D8 may well assist with relaxation and sleep.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

The Cannigma

JUNE 24, 2021

For instance when it comes to pain relief, THC and CBD have shown to be safer than opioids; and for anti-anxiety and sleep aids, CBD does not appear to be habit-forming like benzodiazepines. This can mean taking a small amount of THC each day — for instance in the form of an edible — just to take the edge off and not to get intoxicated.

CBD 75

CBD Microdosing Edibles Sleep 75

CannaMD

AUGUST 26, 2020

As researchers point out: There is no gold standard pharmacological treatment for dependence on cocaine. Exploring alternative therapies, researchers turned their attention to marijuana cannabinoid, cannabidiol – more commonly referred to as CBD. Current Cocaine Treatments. This lack of treatment is especially alarming given the U.N.

Therapy 98

Therapy CBD Research and Development Treatment 98

Project CBD

OCTOBER 26, 2023

There is a growing body of anecdotal and scientific evidence that the “major cannabinoids” tetrahydrocannabinol (THC) and cannabidiol (CBD), certain “minor cannabinoids” (some without a name), and other cannabis compounds have antineoplastic action against cancer cells. THC binds to two types of cannabinoid receptors, CB1 and CB2.

Research and Development 343

Research and Development Cannabinoids Terpenes Pharmaceutical 343

Cannabis Law Report

JANUARY 11, 2019

Accordingly, the Drug Enforcement Administration (DEA) no longer has any claim to interfere with the interstate commerce of hemp products, so as long as the THC level is at or below 0.3%. There is no evidence that CBD is liable to similar abuse and similar ill-effects as substances…such as cannabis or THC.” [7].

Hemp 49

Hemp CBD Law Seed-To-Sale 49

Veriheal

JANUARY 28, 2022

Contributing to Israel’s list of impressive discoveries is a new study, published in Translational Psychiatry , showing that tetrahydrocannabinol (THC) -rich cannabis oil can be effective in treating the symptoms of autism spectrum disorder (ASD). A team of researchers at Tel Aviv University in Tel Aviv, Israel, led by Ph.D.

Oil 99

Oil THC Research and Development Treatment 99

Cannabis Law Report

APRIL 8, 2019

The Commonwealth Parliament’s legislation is in line with a trend towards medicinal legalisation across the developed world in recognition of a growing medical consensus concerning the therapeutic role that “cannabinoids” (chemical compounds derived from plants of the genus cannabis) can play in treating disease and illness.

Medicine 71

Medicine Research and Development Business Cannabis 71

Cannabis Law Report

DECEMBER 20, 2021

Although all three products—hemp, marijuana, and hashish—contain tetrahydrocannabinol (THC), a compound that produces psychoactive effects in humans, the variety of cannabis cultivated for hemp has only small amounts of THC relative to that grown for the production of marijuana or hashish 2. Recent Development.

Seed-To-Sale 52

Seed-To-Sale Hemp Food Clinical Trials 52

Cannabis Law Report

NOVEMBER 12, 2021

Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance addiction, today announced financial results for the first quarter of its fiscal year ending June 30, 2022 and reported recent business highlights. .”

Pharmaceutical 52

Pharmaceutical Clinical Trials Business Research and Development 52

Green Relief

MAY 13, 2018

The benefits of CBD-rich cannabis concentrates for chronic traumatic encephalopathy (CTE) are well-known among football players and other pro athletes. government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”.

THC 64

THC CBD Cannabinoids Research and Development 64

The Cannigma

OCTOBER 19, 2021

While there is no evidence of a doubling effect, the research does indicate that the two substances do augment the effects of one another. In that same study, the researchers found that the level of THC in plasma increased dose-dependently as the amount of alcohol increased. According to at least one study, it might.

Research and Development 128

Research and Development Clinical Trials Edibles THC 128

Cannabis Law Report

OCTOBER 22, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. Currently, the two main cannabinoids from the marijuana plant that are of medical interest are THC and CBD. 9-Tetra-Hydrocannabinol (?9-THC)

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

Cannabis Law Report

OCTOBER 18, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. Currently, the two main cannabinoids from the marijuana plant that are of medical interest are THC and CBD. BX-1: Bionorica SE.

Research and Development 52

Research and Development Pharmaceutical Chronic Pain Therapy 52

CannaMD

MARCH 8, 2020

Researchers summarized five key points from the 2020 review : * We estimate that more than 2 million U.S. Few randomized clinical trials have been conducted or are planned to explore the effects of marijuana on cardiovascular risk. Instead, the study can be seen as a starting point for discussion and further study. Arrhythmia.

Patients 79

Patients Marijuana Research and Development Clinical Trials 79

Kind Meds (Cannabis Education Blog)

DECEMBER 6, 2018

This drastically limits the research opportunities and funding available for cannabis studies. Most cannabis research studies and clinical trials in recent years required researchers to administer THC doses orally in pill form. New Findings From Washington State University Study On Cannabis. Sativa Strains.

Indica 71

Indica Sativa Strains Hybrid 71

Otherside Farms

JANUARY 16, 2019

Microdosing, if you have not yet heard of it, is hotter than just any ordinary trend: Science proves THC and CBD safe, with very real benefits associated with consuming very low doses regularly, as opposed to massive doses all at once. When one talks of a microdose, THC content is no more than a measly 2.5

Microdosing 68

Microdosing THC Research and Development Clinical Trials 68

Alchimia

JANUARY 25, 2022

While this research is certainly worth celebrating, the reality behind the message can be easily misunderstood in this age of social media. It seems that every time a positive clinical study relating to cannabis and COVID comes out, the world gets excited about the medical potential of weed as a miracle medicine to end the pandemic.

Research and Development 98

Research and Development Terpenes CBD Treatment 98

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. For now, we can use a variety of strains in the form of concentrated cannabis oil to hopefully get lucky and find the right one.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

The Joint Blog

OCTOBER 21, 2020

Other than the concentrated oil, it is constantly being added to a variety of creams, makeup, food and drinks as more companies open up to the promised health benefits. . Quality CBD contains absolutely no THC and so, regardless of how much you take, this oil will never make you high. It is worth keeping in mind.

Oil 49

Oil CBD Research and Development Clinical Trials 49

Green Relief

MAY 12, 2018

The benefits of CBD-rich cannabis concentrates for chronic traumatic encephalopathy (CTE) are well-known among football players and other pro athletes. government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Otherside Farms

NOVEMBER 3, 2019

It’s interesting that something like CBD isolate should be enhanced given how much time and energy has been put into developing extraction techniques that even let us arrive at CBD isolate in the first place. It is a non-psychoactive cannabinoid that modulates the effect of psychoactive THC. Enhancing CBD isolate with terpenes.

Terpenes 58

Terpenes CBD Research and Development Cannabinoids 58

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. For now, we can use a variety of strains in the form of concentrated cannabis oil to hopefully get lucky and find the right one.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Cannabis Law Report

DECEMBER 21, 2019

Joseph Billions writes for Cannabis Law Report……So much work has gone into fully determining the medical applications of cannabis, endless works of research have been conducted on how this gift of nature can help make the world a better place and so far there have been numerous breakthroughs among which is autism treatment.

Research and Development 59

Research and Development CBD Conditions Therapy 59

Cannabis Law Report

NOVEMBER 24, 2021

Published by The Journal of Cannabis Research. At the same time, the outlook on cannabis research data is largely positive. Primary sources most frequently used in these reports are peer-reviewed journals or government reports, voices from medical associations or foundations, as well as government and university researchers.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

AUGUST 30, 2019

The National Institute on Drug Abuse published a grant notice to encourage research on the effects of changing US cannabis laws and policies on public health. Michigan’s Department of Agriculture and Rural Development announced the implementation of testing standards for the state’s first crop of industrial hemp.

Banking 45

Banking Research and Development Legislation Programs 45